Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04122118 · ClinicalTrials.gov registry record · NA

Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor

A NA study of Malignant Solid Neoplasm, sponsored by Thomas Jefferson University.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT04122118 is a NA study of Malignant Solid Neoplasm that has completed, run by Thomas Jefferson University. The registered enrollment target is 26 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04122118, a NA study of Malignant Solid Neoplasm, has completed, sponsored by Thomas Jefferson University.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well pharmacist-led transitions of care works in the outpatient oncology infusion center for patients with solid tumor. Having a pharmacist in the outpatient oncology infusion center may help to identify and correct medical related problems and improve overall patient and staff satisfaction. Patients receiving education may benefit from gaining a better understanding of their antineoplastic therapy. Understanding the side effects associated with the therapy may also help patients better be prepared to manage any adverse effects they may experience.

Conditions Studied

Interventions

  • OTHER Survey Administration
  • OTHER Medical Chart Review
  • OTHER Educational Intervention

Study Locations (1)

Pennsylvania

  • Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2019-09-25
Est. Completion 2021-03-05
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT04122118

The ClinicalTrials.gov registry entry for NCT04122118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (98% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT04122118 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04122118 about?

NCT04122118 is a clinical study titled "Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor". This trial studies how well pharmacist-led transitions of care works in the outpatient oncology infusion center for patients with solid tumor. Having a pharmacist in the outpatient oncology infusion center may help to identify and correct medical related problems and improve overall patient and staf...

What is the current status of trial NCT04122118?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-09-25. Estimated completion is 2021-03-05.

What conditions does trial NCT04122118 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm.

What interventions are being tested in trial NCT04122118?

The interventions under investigation include: Survey Administration (OTHER), Medical Chart Review (OTHER), Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT04122118?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04122118 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.